In patients with recurrent symptoms of vaginal discharge and/or perineal itching, have a broad differential diagnosis (e.g., lichen sclerosus et atrophicus, vulvar cancer, contact dermatitis, colovaginal fistula), take a detailed history, and perform a careful physical examination to ensure appropriate investigation or treatment. (Do not assume that the symptoms indicate just a yeast infection.)
In patients with recurrent vaginal discharge, no worrisome features on history or physical examination, and negative tests, make a positive diagnosis of physiologic discharge and communicate it to the patient to avoid recurrent consultation, inappropriate treatment, and investigation in the future.
When bacterial vaginosis and candidal infections are identified through routine vaginal swab or Pap testing, ask about symptoms and provide treatment only when it is appropriate.
In a child with a vaginal discharge, rule out sexually transmitted infections and foreign bodies. (Do not assume that the child has a yeast infection.)
In a child with a candidal infection, look for underlying illness (e.g., immunocompromise, diabetes).
DDx
Infectious vaginal discharge
Bacterial vaginosis (most common cause of vaginal discharge 30%)
Candida vulvovaginitis
Trichomonas vaginalis (STI)
Cervicitis (Gono/Chlam)
Non-infectious vaginal discharge
Physiologic
Atrophic vaginitis (scant discharge)
Foreign body
Non-infectious vulvovaginal pruritus without discharge
Irritant or allergic contact dermatitis (latex, soaps, perfumes)
Lichen planus
Lichen sclerosus
Vulvar cancer
Psoriasis
Colovaginal fistula
Bacterial Vaginosis
Diagnosis
Clinical (Amsel's), require 3 of 4
Adherent and homogenous vaginal discharge (smoothly coats vaginal walls)
Vaginal pH >4.5
Clue cells on saline wet mount
Positive whiff-amine test
Fishy amine odour (before or) after addition of 10% KOH
Other
Gram stain vagina smear with Nugent scoring system (gold standard)
Commercial test DNA probe (eg. Affirm VP III)
Note: Vaginal culture positive for G. vaginalis is not diagnostic due to low specificity (cultured in >50% of healthy asymptomatic women)
Treatment
Oral: Metronidazole 500mg PO BID or Clindamycin 300mg PO BID x 7-14d
Preferred in pregnancy as they have been shown to reduce preterm birth
Topical: Metronidazole gel 0.75% one applicator (5g) PV daily x 5d
Longer courses if multiple recurrences
Consider Metronidazole gel 0.75% one applicator (5g) PV daily x10d then two times per week for 3-6 months